These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 20557835
1. A multicentric, randomized, comparative clinical trial to evaluate the efficacy and safety of S-etodolac in the treatment of osteoarthritis in Indian patients. Sancheti P, Hardikar M, Karne N, Panse J, Singh S, Maria A, Basu I. Int J Clin Pharmacol Ther; 2010 Jul; 48(7):429-34. PubMed ID: 20557835 [Abstract] [Full Text] [Related]
2. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee. Schnitzer TJ, Ballard IM, Constantine G, McDonald P. Clin Ther; 1995 Jul; 17(4):602-12. PubMed ID: 8565024 [Abstract] [Full Text] [Related]
3. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee. Perpignano G, Bogliolo A, Puccetti L. Int J Clin Pharmacol Res; 1994 Jul; 14(5-6):203-16. PubMed ID: 7672877 [Abstract] [Full Text] [Related]
4. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee. Dick WC, Bulstra S, Schardijn GH, Feenstra RM. Clin Ther; 1992 Jul; 14(4):517-26. PubMed ID: 1388092 [Abstract] [Full Text] [Related]
5. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee. Porzio F. Rheumatol Int; 1993 Jul; 13(2 Suppl):S19-24. PubMed ID: 8210920 [Abstract] [Full Text] [Related]
6. A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis. Freitas GG. Curr Med Res Opin; 1990 Jul; 12(4):255-62. PubMed ID: 2150187 [Abstract] [Full Text] [Related]
7. Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study. Dore R, Ballard I, Constantine G, McDonald P. Clin Ther; 1995 Jul; 17(4):656-66. PubMed ID: 8565029 [Abstract] [Full Text] [Related]
8. Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis. Bacon P. Rheumatol Int; 1993 Jul; 13(2 Suppl):S7-12. PubMed ID: 8210924 [Abstract] [Full Text] [Related]
9. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee. Liang TH, Hsu PN. Curr Med Res Opin; 2003 Jul; 19(4):336-41. PubMed ID: 12841927 [Abstract] [Full Text] [Related]
10. Double-blind, randomised, multi-centre clinical study evaluating the efficacy and tolerability of nimesulide in comparison with etodalac in patients suffering from osteoarthritis of the knee. Lücker PW, Pawlowski C, Friedrich I, Faiella F, Magni E. Eur J Rheumatol Inflamm; 1994 Jul; 14(2):29-38. PubMed ID: 7744131 [Abstract] [Full Text] [Related]
11. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee. Khan FM, Williams PI. Curr Med Res Opin; 1992 Jul; 13(1):1-12. PubMed ID: 1468239 [Abstract] [Full Text] [Related]
12. Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee. Karbowski A. Curr Med Res Opin; 1991 Jul; 12(5):309-17. PubMed ID: 1825972 [Abstract] [Full Text] [Related]
13. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis. Puccetti L, Ciompi ML. Int J Clin Pharmacol Res; 1991 Jul; 11(3):143-58. PubMed ID: 1839736 [Abstract] [Full Text] [Related]
14. Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial. Williams PI, Hosie J, Scott DL. Curr Med Res Opin; 1989 Jul; 11(7):463-70. PubMed ID: 2528440 [Abstract] [Full Text] [Related]
15. Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur. Mejjad O, Favre S, Dujardin F, Thomine J, Le Loët X, Weber J. Osteoarthritis Cartilage; 2000 May; 8(3):230-5. PubMed ID: 10806051 [Abstract] [Full Text] [Related]
16. Comparison of etodolac and diclofenac in osteoarthritis of the knee. Grisanti AM, Vaz AA, Samara AM. Clin Ther; 1992 May; 14(6):791-800. PubMed ID: 1286486 [Abstract] [Full Text] [Related]
17. An overview of the efficacy of etodolac in arthritic disorders. Bacon PA. Eur J Rheumatol Inflamm; 1990 May; 10(1):22-34. PubMed ID: 2146130 [Abstract] [Full Text] [Related]
18. A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis. Chikanza IC, Clarke B, Hopkins R, MacFarlane DG, Bird H, Grahame R. Br J Clin Pract; 1994 May; 48(2):67-9. PubMed ID: 8024992 [Abstract] [Full Text] [Related]
19. A comparison of the efficacy of etodolac SR (Lodine SR) and etodolac (Lodine) in patients with rheumatoid arthritis or osteoarthritis. Dreiser RL. Rheumatol Int; 1993 May; 13(2 Suppl):S13-8. PubMed ID: 8210919 [Abstract] [Full Text] [Related]
20. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Gana TJ, Pascual ML, Fleming RR, Schein JR, Janagap CC, Xiang J, Vorsanger GJ, 023 Study Group. Curr Med Res Opin; 2006 Jul; 22(7):1391-401. PubMed ID: 16834838 [Abstract] [Full Text] [Related] Page: [Next] [New Search]